SJS Investment Consulting’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.5K Buy
889
+46
+5% +$4.03K 0.01% 279
2026
Q1
$71.8K Sell
843
-52
-6% -$4.63K 0.01% 270
2025
Q4
$70.7K Buy
895
+162
+22% +$12.7K 0.01% 256
2025
Q3
$58.6K Buy
733
+513
+233% +$43.8K 0.01% 242
2025
Q2
$20K Sell
220
-17
-7% -$1.55K ﹤0.01% 282
2025
Q1
$22.2K Buy
237
+6
+3% +$537 ﹤0.01% 279
2024
Q4
$21K Sell
231
-1
-0.4% -$95 ﹤0.01% 272
2024
Q3
$24.1K Buy
232
+4
+2% +$408 ﹤0.01% 265
2024
Q2
$22.1K Buy
228
+6
+3% +$553 ﹤0.01% 256
2024
Q1
$20K Sell
222
-107
-33% -$9.07K ﹤0.01% 282
2023
Q4
$26.2K Buy
329
+108
+49% +$8.12K 0.01% 217
2023
Q3
$15.7K Sell
221
-15
-6% -$1.12K ﹤0.01% 253
2023
Q2
$18.2K Sell
236
-5
-2% -$387 ﹤0.01% 226
2023
Q1
$18.1K Buy
241
+3
+1% +$223 ﹤0.01% 233
2022
Q4
$18.8K Buy
238
+12
+5% +$900 0.01% 238
2022
Q3
$16K Buy
+226
New +$17.7K 0.01% 253
2022
Q1
$16K Buy
220
+20
+10% +$1.58K ﹤0.01% 327
2021
Q4
$17K Buy
+200
New +$15.6K 0.01% 294

Other funds holding CL

SJS Investment Consulting's CL Position: Q2 2026 in Review

SJS Investment Consulting increased its Colgate-Palmolive (CL) stake by 5.5% in Q2 2026, buying an estimated $4.03K and bringing the position to 889 shares worth $81.5K. The position accounts for 0.01% of the portfolio, ranked #279.

SJS Investment Consulting first reported a position in CL in Q4 2021 and has held it in 18 quarters since. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • SJS Investment Consulting held 889 shares of Colgate-Palmolive worth $81.5K as of Q2 2026.
  • SJS Investment Consulting bought 46 Colgate-Palmolive shares in Q2 2026, an estimated $4.03K.
  • Colgate-Palmolive made up 0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #279 holding.
  • SJS Investment Consulting first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 18 quarters since.
  • 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.